- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 11-05-2025 4:00pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 231.8M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 144.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.58 - $5.30 | Next Earning Date: | 11-04-2025 |
| Revenue: | $73,297,000 | Revenue Growth: | 13.66% |
| Revenue Growth (this year): | 16.6% | Revenue Growth (next year): | 19.09% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
GlobeNewswire
2 days ago
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
GuruFocus.com
3 days ago
Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q3 2025 Result
Simply Wall St.
7 days ago
October 2025 Penny Stocks With Growth Potential
GlobeNewswire
13 days ago
AI in Biotechnology Market to Reach $11.4 Billion by 2030
PR Newswire
16 days ago
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
GlobeNewswire
17 days ago
AI in Biotechnology Research Report 2025: An $11.4 Billion Market by 2030, Dominated by NVIDIA, Tempus AI, Recursion Pharmaceuticals, Schrodinger, and Sophia Genetics
MT Newswires
20 days ago
Sector Update: Health Care Stocks Advance Thursday Afternoon
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.